LPL Financial’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-41,864
| Closed | -$123K | – | 3330 |
|
|
2018
Q1 | $123K | Buy |
41,864
+3,695
| +10% | +$10.9K | ﹤0.01% | 3035 |
|
|
2017
Q4 | $105K | Sell |
38,169
-55,733
| -59% | -$153K | ﹤0.01% | 2907 |
|
|
2017
Q3 | $318K | Sell |
93,902
-2,205
| -2% | -$7.47K | ﹤0.01% | 2305 |
|
|
2017
Q2 | $237K | Sell |
96,107
-2,427
| -2% | -$5.99K | ﹤0.01% | 2455 |
|
|
2017
Q1 | $227K | Sell |
98,534
-2,653
| -3% | -$6.11K | ﹤0.01% | 2403 |
|
|
2016
Q4 | $226K | Sell |
101,187
-46,851
| -32% | -$105K | ﹤0.01% | 2390 |
|
|
2016
Q3 | $484K | Sell |
148,038
-14,377
| -9% | -$47K | ﹤0.01% | 1748 |
|
|
2016
Q2 | $516K | Sell |
162,415
-146,865
| -47% | -$467K | ﹤0.01% | 1641 |
|
|
2016
Q1 | $1.02M | Buy |
309,280
+79,967
| +35% | +$265K | ﹤0.01% | 1658 |
|
|
2015
Q4 | $793K | Buy |
229,313
+78,293
| +52% | +$271K | ﹤0.01% | 1864 |
|
|
2015
Q3 | $790K | Buy |
151,020
+12,467
| +9% | +$65.2K | ﹤0.01% | 1420 |
|
|
2015
Q2 | $856K | Buy |
138,553
+10,312
| +8% | +$63.7K | ﹤0.01% | 1488 |
|
|
2015
Q1 | $919K | Buy |
128,241
+61,175
| +91% | +$438K | ﹤0.01% | 1414 |
|
|
2014
Q4 | $517K | Sell |
67,066
-8,726
| -12% | -$67.3K | ﹤0.01% | 1747 |
|
|
2014
Q3 | $569K | Sell |
75,792
-64,352
| -46% | -$483K | ﹤0.01% | 1687 |
|
|
2014
Q2 | $1.36M | Buy |
140,144
+32
| +0% | +$310 | 0.01% | 1125 |
|
|
2014
Q1 | $1.16M | Sell |
140,112
-1,881
| -1% | -$15.6K | 0.01% | 1166 |
|
|
2013
Q4 | $1.2M | Buy |
141,993
+26,288
| +23% | +$222K | 0.01% | 1120 |
|
|
2013
Q3 | $929K | Buy |
115,705
+31,897
| +38% | +$256K | 0.01% | 1228 |
|
|
2013
Q2 | $647K | Buy |
+83,808
| New | +$647K | ﹤0.01% | 1390 |
|